We noted, however, that tumor cells expressing shRNA constructs targeting PKM2 do not have generalized growth defects but rather have very specific cell cycle defects, accumulating with a greater than 2N DNA content and in a manner consistent with an inability to enter mitosis (13, 15). Here, PKM is linked to neoplasm.